Filing Details
- Accession Number:
- 0001127602-16-054819
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-06 16:39:28
- Reporting Period:
- 2016-06-02
- Filing Date:
- 2016-06-06
- Accepted Time:
- 2016-06-06 16:39:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538555 | W Thomas Loewald | 81 Wyman Street Waltham MA 02451 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-02 | 5,000 | $73.24 | 49,169 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-06-02 | 10,000 | $73.24 | 59,169 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-02 | 15,000 | $152.84 | 44,169 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-06-02 | 5,000 | $0.00 | 5,000 | $73.24 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-06-02 | 10,000 | $0.00 | 10,000 | $73.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,700 | 2020-02-26 | No | 4 | M | Direct | |
| 15,700 | 2020-02-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.38 to $153.30, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 26, 2014, 2015, and 2016, and the last installment becomes exercisable on February 26, 2017.
Billionaire Hedge Funds
